EMPOWER PHARMA
Live / Allowed — Published for opposition (as of 17 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 01 Dec 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98294319
- Mark type
- Stylized text
- Filed
- 01 Dec 2023
- Published for opposition
- 03 Sept 2024
- Attorney of record
- JOHN A YATES
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for weight management, hormone replacement therapy, intravenous therapy, intravenous nutrition, injectable therapy, dietary nutrition, mental health, skin care, sexual dysfunction, fertility, men's health, and women's health; pharmaceutical preparations for the prevention, reduction, and treatment of cardiovascular, lymphatic, respiratory, pulmonary, neurological, renal, gastrointestinal, musculoskeletal, dermatological, allergic, inflammatory, autoimmune, gynecological, genetic, longevity, metabolic, and pain conditions; disinfecting wipes; and sanitizing wipes
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals
Owner
- Empower Clinic Services, LLC, Houston, TX, US
- Empower Clinic Services, LLC, Houston, TX, US
Prosecution history
- 16 Mar 2026 — TTAB RELEASE CASE TO TRADEMARKS
- 16 Mar 2026 — OPPOSITION TERMINATED NO. 999999
- 30 Jan 2026 — OPPOSITION DISMISSED NO. 999999
- 01 Jan 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 03 Oct 2024 — OPPOSITION INSTITUTED NO. 999999
- 02 Oct 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 03 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Sept 2024 — PUBLISHED FOR OPPOSITION
- 14 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Jul 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Jun 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Jun 2024 — NON-FINAL ACTION E-MAILED